The abnormal elevation in hemoglobin (Hb) concentration or hematocrit results in a clinical condition known as polycythemia.[1] In a clinical setting, this elevation is manifested as an increase in the patient’s levels of Hb and hematocrit (HCT). The gene discussed is GSTM1; the disease is polycythemia.